David Jakeman is VP OF FINANCE AND ACCOUNTING at CHIMERIX INC (CMRX). They have made 4 open-market trades across 1 company since 2020, most recently 2025-04-21.
CIK 0001780556
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CMRX | 148,987 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2025-02-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMRX | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $4.53 | $1K | -6.1% | +67.7% | N/A |
| CMRX | SELL · 10b5-1 | 2025-01-30 | 2025-01-31 | $4.10 | $11K | +14.7% | +30.2% | N/A |
| CMRX | SELL · 10b5-1 | 2024-02-14 | 2024-02-16 | $1.04 | $3K | -1.7% | -6.0% | -17.1% |
| CMRX | SELL · 10b5-1 | 2023-09-28 | 2023-09-28 | $0.99 | $4K | +1.1% | -1.3% | -2.3% |
| CMRX | SELL · 10b5-1 | 2023-01-26 | 2023-01-26 | $1.76 | $6K | +2.2% | -11.2% | -35.7% |
| CMRX | SELL | 2022-09-29 | 2022-09-30 | $1.86 | $8K | -8.1% | -10.6% | -5.6% |
| CMRX | SELL · 10b5-1 | 2022-02-04 | 2022-02-04 | $5.56 | $18K | +5.9% | -3.9% | -14.8% |
| CMRX | SELL | 2021-09-30 | 2021-09-30 | $6.19 | $28K | -7.6% | -11.9% | +9.0% |
| CMRX | SELL · 10b5-1 | 2021-04-05 | 2021-04-07 | $9.68 | $12K | -11.8% | -7.5% | -10.8% |
| CMRX | SELL · 10b5-1 | 2021-01-28 | 2021-01-29 | $8.61 | $28K | +18.1% | +16.6% | +5.4% |
| CMRX | SELL | 2020-10-02 | 2020-10-02 | $2.48 | $11K | +16.6% | +6.9% | +95.5% |
| CMRX | SELL | 2020-02-07 | 2020-02-11 | $1.70 | $4K | +2.4% | -16.6% | +84.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.